Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Biol Res ; 46(2): 207-13, 2013.
Article in English | MEDLINE | ID: mdl-23959020

ABSTRACT

Oxidant/antioxidant imbalance has been reported in some infectious diseases, including community-acquired pneumonia (CAP). The aim was to assess the antioxidant status in adults with CAP and its relationship with clinical severity at admission. Fifty-nine patients with CAP were enrolled and categorized at admission by the FINE score, from July 2010 to October 2012. In the same period 61 controls were enrolled. Plasma samples were obtained at admission for determination of the ferric reducing ability of plasma (FRAP) and lipid peroxidation (8-isoprostane). Erythrocyte reduced (GSH)/oxidized (GSSG) glutathione, malondialdehyde (MDA) and antioxidant enzyme activity were assessed. Antioxidant status in adults with CAP represented by FRAP and the GSH/GSSG ratio were 16.8% (p=0.03) and 39.7% (p=0.04) lower than control values, respectively. In addition, FRAP values showed a positive correlation with GSH/GSSG ratio (r=0.852; p<0.02; n=59). The CAP group showed greater lipid peroxidation in both plasma and erythrocytes. The FINE score correlated negatively with FRAP (r= -0.718; p<0.05; n=59) and positively with MDA and F2 isoprostane levels (r=0.673; p<0.05; n=59; r=0.892; p<0.01; n=59, respectively). Antioxidant status alterations correlated with clinical severity. The FRAP assay and lipid peroxidation biomarkers may provide a useful parameter for estimating the severity and the clinical outcome of patients with CAP.


Subject(s)
Erythrocytes/metabolism , Glutathione/blood , Lipid Peroxidation/physiology , Oxidative Stress/physiology , Pneumonia/metabolism , Aged , Biomarkers/metabolism , Case-Control Studies , Catalase/blood , Catalase/metabolism , Community-Acquired Infections/metabolism , Cross-Sectional Studies , F2-Isoprostanes/blood , Female , Glutathione Peroxidase/blood , Glutathione Peroxidase/metabolism , Humans , Male , Malondialdehyde/blood , Middle Aged , Severity of Illness Index , Superoxide Dismutase/blood , Superoxide Dismutase/metabolism
2.
Thorax ; 68(11): 1000-6, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23783373

ABSTRACT

BACKGROUND: Adult community-acquired pneumonia (CAP) is a relevant worldwide cause of morbidity and mortality, however the aetiology often remains uncertain and the therapy is empirical. We applied conventional and molecular diagnostics to identify viruses and atypical bacteria associated with CAP in Chile. METHODS: We used sputum and blood cultures, IgG/IgM serology and molecular diagnostic techniques (PCR, reverse transcriptase PCR) for detection of classical and atypical bacteria (Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumoniae) and respiratory viruses (adenovirus, respiratory syncytial virus (RSV), human metapneumovirus, influenza virus, parainfluenzavirus, rhinovirus, coronavirus) in adults >18 years old presenting with CAP in Santiago from February 2005 to September 2007. Severity was qualified at admission by Fine's pneumonia severity index. RESULTS: Overall detection in 356 enrolled adults were 92 (26%) cases of a single bacterial pathogen, 80 (22%) cases of a single viral pathogen, 60 (17%) cases with mixed bacterial and viral infection and 124 (35%) cases with no identified pathogen. Streptococcus pneumoniae and RSV were the most common bacterial and viral pathogens identified. Infectious agent detection by PCR provided greater sensitivity than conventional techniques. To our surprise, no relationship was observed between clinical severity and sole or coinfections. CONCLUSIONS: The use of molecular diagnostics expanded the detection of viruses and atypical bacteria in adults with CAP, as unique or coinfections. Clinical severity and outcome were independent of the aetiological agents detected.


Subject(s)
Bacteria/genetics , Community-Acquired Infections/epidemiology , Molecular Diagnostic Techniques/methods , Pneumonia, Bacterial/epidemiology , Pneumonia, Viral/epidemiology , Viruses/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Chile/epidemiology , Community-Acquired Infections/diagnosis , DNA, Bacterial/analysis , DNA, Viral/analysis , Diagnosis, Differential , Female , Humans , Incidence , Male , Middle Aged , Pneumonia, Bacterial/diagnosis , Pneumonia, Bacterial/microbiology , Pneumonia, Viral/diagnosis , Pneumonia, Viral/virology , Reproducibility of Results , Retrospective Studies , Severity of Illness Index , Sputum/microbiology , Sputum/virology , Young Adult
3.
Biol. Res ; 46(2): 207-213, 2013. graf, tab
Article in English | LILACS | ID: lil-683999

ABSTRACT

Oxidant/antioxidant imbalance has been reported in some infectious diseases, including community-acquired pneumonia (CAP). The aim was to assess the antioxidant status in adults with CAP and its relationship with clinical severity at admission. Fifty-nine patients with CAP were enrolled and categorized at admission by the FINE score, from July 2010 to October 2012. In the same period 61 controls were enrolled. Plasma samples were obtained at admission for determination of the ferric reducing ability of plasma (FRAP) and lipid peroxidation (8-isoprostane). Erythrocyte reduced (GSH)/oxidized (GSSG) glutathione, malondialdehyde (MDA) and antioxidant enzyme activity were assessed. Antioxidant status in adults with CAP represented by FRAP and the GSH/GSSG ratio were 16.8% (p=0.03) and 39.7% (p=0.04) lower than control values, respectively. In addition, FRAP values showed a positive correlation with GSH/GSSG ratio (r=0.852; p<0.02; n=59). The CAP group showed greater lipid peroxidation in both plasma and erythrocytes. The FINE score correlated negatively with FRAP (r= -0.718; p<0.05; n=59) and positively with MDA and F2 isoprostane levels (r=0.673; p<0.05; n=59; r=0.892; p<0.01; n=59, respectively). Antioxidant status alterations correlated with clinical severity. The FRAP assay and lipid peroxidation biomarkers may provide a useful parameter for estimating the severity and the clinical outcome of patients with CAP.


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Erythrocytes/metabolism , Glutathione/blood , Lipid Peroxidation/physiology , Oxidative Stress/physiology , Pneumonia/metabolism , Biomarkers/metabolism , Case-Control Studies , Cross-Sectional Studies , Catalase/blood , Catalase/metabolism , Community-Acquired Infections/metabolism , /blood , Glutathione Peroxidase/blood , Glutathione Peroxidase/metabolism , Malondialdehyde/blood , Severity of Illness Index , Superoxide Dismutase/blood , Superoxide Dismutase/metabolism
4.
Clin Infect Dis ; 54(7): 905-12, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22238168

ABSTRACT

BACKGROUND: Respiratory syncytial virus (RSV) has been implicated in the etiology of adult community-acquired pneumonia (CAP). We investigated RSV infection in Chilean adults with CAP using direct viral detection, real-time reverse-transcription polymerase chain reaction (rtRT-PCR), and serology (microneutralization assay). METHODS: RSV, other respiratory viruses, and bacteria were studied by conventional and molecular techniques in adults aged ≥18 years presenting with CAP to the healthcare facilities in Santiago, Chile from February 2005 through December 2007. RESULTS: All 356 adults with CAP enrolled had an acute blood sample collected at enrollment, and 184 had a convalescent blood sample. RSV was detected in 48 cases (13.4%). Immunofluorescence assay and viral isolation each detected only 1 infection (0.2%), whereas rtRT-PCR was positive in 32 (8.9%) cases and serology was positive in 20 (10.8%) cases. CAP clinical characteristics were similar in RSV-infected and non-RSV-infected cases. RSV-specific geometric mean serum-neutralizing antibody titer (GMST) was significantly lower at admission in the 48 RSV-infected cases compared with 308 non-RSV-infected adults (GMST in log(2): RSV/A 8.1 vs 8.9, and RSV/B 9.3 vs 10.4; P < .02). CONCLUSIONS: RSV infection is frequent in Chilean adults with CAP. Microneutralization assay was as sensitive as rtRT-PCR in detecting RSV infection and is a good adjunct assay for diagnostic research. High RSV-specific serum-neutralizing antibody levels were associated with protection against common and severe infection. The development of a vaccine could prevent RSV-related CAP in adults.


Subject(s)
Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Community-Acquired Infections/epidemiology , Pneumonia, Viral/epidemiology , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Virus, Human/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Chile/epidemiology , Clinical Laboratory Techniques/methods , Community-Acquired Infections/diagnosis , Community-Acquired Infections/immunology , Community-Acquired Infections/virology , Female , Humans , Male , Middle Aged , Neutralization Tests/methods , Pneumonia, Viral/diagnosis , Pneumonia, Viral/immunology , Pneumonia, Viral/virology , Real-Time Polymerase Chain Reaction/methods , Respiratory Syncytial Virus Infections/diagnosis , Respiratory Syncytial Virus Infections/immunology , Reverse Transcriptase Polymerase Chain Reaction/methods , Seroepidemiologic Studies , Young Adult
5.
J Med Microbiol ; 59(Pt 8): 925-929, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20448063

ABSTRACT

This study was conducted to determine the types of M. pneumoniae prevalent in adults presenting with community-acquired pneumonia during an epidemic period, and to scrutinize a variable region of the RepMP4 element for the detection of P1 variants. All 23 clinical specimens PCR-positive for M. pneumoniae obtained in two hospitals in Santiago, Chile, from 2005 to 2006 were typed by a multiplex PCR directly and then the RepMP4 fragment of 18 specimens was sequenced. A predominance of M. pneumoniae type 2 was found, 18 (78.3 %) specimens being grouped as type 2 and 5 (21.7 %) as type 1. Co-infection of M. pneumoniae with other respiratory pathogens was found in 10/23 (43.4 %) patients, but their frequency was not related to the M. pneumoniae type. Sequence analysis revealed a single nucleotide polymorphism, a transition mutation, in 50 % of amplicons belonging to type 1 and in 71.4 % of amplicons of type 2. The nucleotide changes were synonymous in each P1 variant. In conclusion, during the 2005-2006 epidemic in Santiago, both types of M. pneumoniae circulated. Although the analysed area in the RepMP4 was small, we detected the existence of P1 variants in the two types of this organism.


Subject(s)
Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Disease Outbreaks , Mycoplasma pneumoniae/classification , Mycoplasma pneumoniae/isolation & purification , Pneumonia, Mycoplasma/epidemiology , Pneumonia, Mycoplasma/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Bacterial Typing Techniques , Chile/epidemiology , Cluster Analysis , DNA Fingerprinting , DNA, Bacterial/genetics , Humans , Middle Aged , Molecular Sequence Data , Mutation, Missense , Mycoplasma pneumoniae/genetics , Phylogeny , Polymerase Chain Reaction , Sequence Analysis, DNA , Sequence Homology , Young Adult
6.
J Med Microbiol ; 57(Pt 12): 1491-1495, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19018018

ABSTRACT

Diagnosis of pneumonia caused by Mycoplasma pneumoniae in adults is hampered by a lack of rapid and standardized tests for detection. This prospective study was conducted to compare the diagnostic values of an indirect immunofluorescence assay and a 16S rRNA gene PCR for the diagnosis of M. pneumoniae pneumonia in adults. From February 2005 to January 2008, 357 patients (53.8 % males, median age 63 years, range 18-94) admitted for community-acquired pneumonia (CAP) to two hospitals in Santiago, Chile, were enrolled in the study. Thirty-two patients (9.0 %) met the criteria of current or recent M. pneumoniae infection, and laboratory diagnosis was definitive in 26 cases (81.2 %) and presumptive in six cases (18.8 %). Among the 32 M. pneumoniae infections, the PCR assay was positive in 23 (71.9 %) and the serology in 27 (84.4 %) of the cases. IgM was positive in acute-phase serum specimens in 13 cases (40.6 %) of M. pneumoniae infections. Using serology as the gold standard, the sensitivity, specificity, and positive and negative predictive values of the PCR were 66.7, 98.5, 78.3 and 97.3 %, respectively, whereas the global agreement of the methods was 343/357 (96.1 %). The frequency of M. pneumoniae CAP cases declined significantly during the second year of study, suggesting the end of an epidemic period. In conclusion, although good global agreement was found between PCR and serology, the lower sensitivity of the PCR leads us to recommend the use of both procedures in parallel to confirm M. pneumoniae in CAP in adults.


Subject(s)
Antibodies, Bacterial/blood , Community-Acquired Infections/microbiology , Mycoplasma pneumoniae/immunology , Mycoplasma pneumoniae/isolation & purification , Pneumonia, Mycoplasma/microbiology , Polymerase Chain Reaction/methods , Adolescent , Adult , Aged , Aged, 80 and over , Chile/epidemiology , Community-Acquired Infections/diagnosis , Community-Acquired Infections/epidemiology , DNA, Bacterial/analysis , DNA, Bacterial/isolation & purification , Female , Fluorescent Antibody Technique, Indirect/methods , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Middle Aged , Mycoplasma pneumoniae/genetics , Pneumonia, Mycoplasma/diagnosis , Pneumonia, Mycoplasma/epidemiology , Pneumonia, Mycoplasma/immunology , RNA, Ribosomal, 16S/genetics , Sensitivity and Specificity , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...